The acute effect of corticosteroids on the release and biosynthesis of gastrin still remains unclear. We report the effect of short-term administration of dexamethasone on the antral gastrin gene expression and gastrin levels in 6 dogs, which were treated with dexamethasone (1.5 mg/kg, i.m. daily) for 3 days. One day after treatment, gastrin mRNA levels increased (152 +/- 14%), but serum and tissue gastrin showed no significant changes. With 2 and 3 days of dexamethasone treatment, gastrin mRNA (2 days: 163 +/- 28%, 3 days: 170 +/- 22%), serum gastrin (2 days: from 94 +/- 12 to 168 +/- 23 pg/ml, 3 days: to 180 +/- 16 pg/ml) and tissue gastrin concentration (2 days: from 480 +/- 32 to 664 +/- 31 pg/mg tissue protein, 3 days: to 708 +/- 45 pg/mg tissue protein) significantly increased. However, gastrin mRNA levels were not increased even after 1 day culture of canine antral tissue with dexamethasone in vitro. These findings suggest that short-term administration of corticosteroid may increase the canine gastrin gene expression in vivo by an unknown pathway.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000201025 | DOI Listing |
Background: Despite the guidelines' appeal to treat patients with deep vein thrombosis and low-risk pulmonary embolism in outpatient settings, the real-world evidence shows a high prevalence of inpatient therapy leading to unwarranted health resource utilization. The study aimed to assess the efficacy and safety of rivaroxaban in outpatient settings compared to inpatient treatment.
Methods: A propensity score-matched comparison with a historical inpatient population was performed based on a retrospective analysis of patients with deep vein thrombosis and without pulmonary embolism treated as outpatients with oral rivaroxaban.
J Intensive Med
January 2025
Department of Critical Care Medicine, The First Hospital of Jilin University, Changchun, Jilin, China.
Background: The effect of the modality of hydrocortisone administration on clinical outcomes in patients with septic shock remains uncertain. This systematic review and meta-analysis evaluate the impact of intermittent bolus and continuous infusion of hydrocortisone on these outcomes.
Methods: We searched the PubMed, Embase databases, and Cochrane Library for randomized controlled trials (RCTs) and cohort studies published from inception to January 1, 2023.
PLoS One
January 2025
Department of Electrical Engineering, College of Engineering, Taif University, Taif, Saudi Arabia.
Modernizing power systems into smart grids has introduced numerous benefits, including enhanced efficiency, reliability, and integration of renewable energy sources. However, this advancement has also increased vulnerability to cyber threats, particularly False Data Injection Attacks (FDIAs). Traditional Intrusion Detection Systems (IDS) often fall short in identifying sophisticated FDIAs due to their reliance on predefined rules and signatures.
View Article and Find Full Text PDFExpert Rev Hematol
January 2025
Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Introduction: The clinical management of the inherited bleeding disorder von Willebrand disease (VWD) focuses on normalizing circulating levels of von Willebrand factor (VWF) and factor VIII (FVIII) to prevent or control bleeding events. The heterogeneous nature of VWD, however, complicates effective disease management and development of universal treatment guidelines.
Areas Covered: The current treatment modalities of VWD and their limitations are described and why this prompts the development of new treatment approaches.
Aust Vet J
January 2025
North Shore Veterinary Specialist & Emergency Centre, Artarmon, New South Wales, Australia.
Objectives: To identify if chemotherapeutic drugs in the CHOP-based protocol led to an increase in renal parameters in dogs with lymphoma during therapy and investigate whether factors such as prednisolone use or age affected this result.
Methods: Data were obtained retrospectively from private referral practice records of dogs diagnosed with lymphoma receiving a CHOP-based chemotherapy protocol between 2015 and 2019. Dogs included received a CHOP-based protocol as their first treatment, received four full cycles and were in remission at the end of the protocol.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!